tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
GMAB is currently covered by 6 analysts with an average price target of $28.95. This is a potential upside of $8.3 (40.19%) from yesterday's end of day stock price of $20.65.
Genmab AS's activity chart (see below) currently has 61 price targets and 101 ratings on display. The stock rating distribution of GMAB is 18.64% SELL, 79.66% BUY and 1.69% HOLD.
Analysts average stock forecasts to be materialized ratio is 24.65% with an average time for these price targets to be met of 46.36 days.
Highest price target for GMAB is $50, Lowest price target is $31, average price target is $28.95.
Most recent stock forecast was given by ETZER DAROUT from BMO on 08-Nov-2024.
Currently out of the existing stock ratings of GMAB, 11 are a SELL (18.64%), 47 are a BUY (79.66%), 1 are a HOLD (1.69%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$48
$27.41 (133.12%)
$48
14 days ago
(08-Nov-2024)
1/3 (33.33%)
$24.97 (108.42%)
26
Buy
$50
$29.41 (142.84%)
$50
1 months 6 days ago
(16-Oct-2024)
9/46 (19.57%)
$27.4 (121.24%)
131
Buy
$50
$29.41 (142.84%)
$53
2 months 13 days ago
(09-Sep-2024)
6/13 (46.15%)
$22.54 (82.08%)
87
Hold
$31
$10.41 (50.56%)
$32
2 months 18 days ago
(04-Sep-2024)
16/18 (88.89%)
$3.41 (12.36%)
146
Buy
$47
$26.41 (128.27%)
$46
4 months 26 days ago
(27-Jun-2024)
0/3 (0%)
$21.42 (83.74%)
What is GMAB (Genmab AS) average time for price targets to be met?
Which analyst has the current highest performing score on GMAB (Genmab AS) with a proven track record?
Which analyst has the most public recommendations on GMAB (Genmab AS)?
Which analyst is the currently most bullish on GMAB (Genmab AS)?
Which analyst is the currently most reserved on GMAB (Genmab AS)?
